Works matching IS 02536269 AND DT 2019 AND VI 42 AND IP 8
Results: 9
Hesperetin inhibits neuroinflammation on microglia by suppressing inflammatory cytokines and MAPK pathways.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 695, doi. 10.1007/s12272-019-01174-5
- By:
- Publication type:
- Article
Isoorientin improves scopolamine-induced cognitive impairments by restoring the cholinergic system, antioxidant defense, and p-CREB/BDNF signaling in the hippocampus and frontal cortex.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 722, doi. 10.1007/s12272-019-01172-7
- By:
- Publication type:
- Article
Astragalin reduces lipopolysaccharide-induced acute lung injury in rats via induction of heme oxygenase-1.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 704, doi. 10.1007/s12272-019-01171-8
- By:
- Publication type:
- Article
Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin–proteasome pathway.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 684, doi. 10.1007/s12272-019-01170-9
- By:
- Publication type:
- Article
Apoptotic cell clearance in the tumor microenvironment: a potential cancer therapeutic target.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 658, doi. 10.1007/s12272-019-01169-2
- By:
- Publication type:
- Article
Preventive approach for overcoming dementia.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 647, doi. 10.1007/s12272-019-01168-3
- By:
- Publication type:
- Article
Correction to: Pharmacology of natural radioprotectors.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 712, doi. 10.1007/s12272-019-01163-8
- By:
- Publication type:
- Article
Camptothecin activates SIRT1 to promote lipid catabolism through AMPK/FoxO1/ATGL pathway in C<sub>2</sub>C<sub>12</sub> myogenic cells.
- Published in:
- Archives of Pharmacal Research, 2019, v. 42, n. 8, p. 672, doi. 10.1007/s12272-019-01155-8
- By:
- Publication type:
- Article